Clinically available pharmacogenomics tests

D. A. Flockhart, T. Skaar, D. S. Berlin, T. E. Klein, A. T. Nguyen

Research output: Contribution to journalReview article

57 Scopus citations

Abstract

The development of robust and clinically valuable pharmacogenomic tests has been anticipated to be one of the first tangible results of the Human Genome Project. Despite both obvious and unanticipated obstacles, a number of tests have now become available in various practice settings. Lessons can be learned from examination of these tests, the evidence that has catalyzed their use, their value to prescribers, and their merit as tools for personalizing therapeutics.

Original languageEnglish (US)
Pages (from-to)109-113
Number of pages5
JournalClinical Pharmacology and Therapeutics
Volume86
Issue number1
DOIs
StatePublished - Jul 1 2009

ASJC Scopus subject areas

  • Pharmacology
  • Pharmacology (medical)

Fingerprint Dive into the research topics of 'Clinically available pharmacogenomics tests'. Together they form a unique fingerprint.

  • Cite this

    Flockhart, D. A., Skaar, T., Berlin, D. S., Klein, T. E., & Nguyen, A. T. (2009). Clinically available pharmacogenomics tests. Clinical Pharmacology and Therapeutics, 86(1), 109-113. https://doi.org/10.1038/clpt.2009.39